COMPARISON OF BUPIVACAINE VERSUS BUPIVACAINE WITH FENTANYL INTRATHECALLY IN CESAREAN SECTION

Authors

  • JAYSHRI PRAJAPATI Department of Anesthesiology, GMERS Medical College, Himmatnagar, Gujarat, India.
  • REKHA BAYER Department of Anesthesiology, GMERS Medical College, Himmatnagar, Gujarat, India.
  • HIMANSHU PRAJAPATI Department of Anesthesiology, GMERS Medical College, Himmatnagar, Gujarat, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i12.45924

Keywords:

bupivacaine, fentanyl, intrathecally, spinal anaesthesia

Abstract

Objectives: The objectives of the study were to evaluate the efficacy and safety of fentanyl with hyperbaric bupivacaine in spinal anesthesia for caesarean section.

Methods: This prospective observational study was conducted in anesthesia department of tertiary care teaching hospital of Gujarat. Group A was given 2.0 ml of 0.5% hyperbaric bupivacaine with 0.25 ml of normal saline and Group B received 2.0 ml of 0.5% hyperbaric bupivacaine with 0.25 ml of injection fentanyl (12.5 μg). Characteristics of sensory blockade, motor blockade, analgesia, APGAR score, surgical variables, hemodynamic parameters, and complications were noted and compared in both the groups.

Results: There was no significant difference in onset of sensory block in both groups (p>0.05) but there was statistically significant difference present regarding duration of regression of sensory blockade (p<0.05). Time of motor onset and time to get Grade 0 from Grade 3 block were comparable in both groups (p>0.05). Duration of complete analgesia and duration of effective analgesia were significantly prolonged in Group B as compared to Group A (p<0.001). There was also no statistically significant difference observed in mean pulse rate, systolic blood pressure and diastolic blood pressure, and mean arterial pressure in both the groups during entire period of time (p>0.05).

Conclusions: The present study concluded that intrathecal fentanyl 12.5 μg with bupivacaine produce prolonged sensory block as well as post-operative analgesia compared to bupivacaine alone for cesarean section with insignificant hemodynamic changes without affecting neonatal outcome.

Downloads

Download data is not yet available.

Author Biographies

JAYSHRI PRAJAPATI, Department of Anesthesiology, GMERS Medical College, Himmatnagar, Gujarat, India.

Associate Professor, Department of Anesthesiology

REKHA BAYER, Department of Anesthesiology, GMERS Medical College, Himmatnagar, Gujarat, India.

Assistant Professor, Department of Anesthesiology

HIMANSHU PRAJAPATI, Department of Anesthesiology, GMERS Medical College, Himmatnagar, Gujarat, India.

Junior Resident, Department of Anesthesiology

References

Antoine C, Young BK. Cesarean section one hundred years 1920- 2020: The good, the bad and the ugly. J Perinat Med 2020;49:5-16. doi: 10.1515/jpm-2020-0305, PMID 32887190

Miller RD. Miller’s Anesthesia. 6th ed. New York: Churchill Livingstone; 2005. p. 232-329.

Brizzi A, Greco F, Malvasi A, Valerio A, Martino V. Comparison of sequential combined spinal-epidural anesthesia and spinal anesthesia for cesarean section. Minerva Anestesiol 2005;71:701-9. PMID 16278629

Gogarten W. Spinal anesthesia for obstetrics. Best Pract Res Clin Anaesthesiol 2003;17:377-92. doi: 10.1016/s1521-6896(02)00116-7, PMID 14529009

Hallworth SP, Fernando R, Columb MO, Stocks GM. The effect of posture and baricity on spread of intrathecal bupivacaine for elective cesarean delivery. Anesth Analg 2005;100:1159-65. doi: 10.1213/01. ANE.0000149548.88029.A2, PMID 15781538

Rout CC, Rocke DA, Levin J, Gouws E, Reddy D. A reevaluation of the role of crystalloid preload in the prevention of hypotension associated with spinal anesthesia for elective cesarean section Anesthesiology 1993;79:262-9. doi: 10.1097/00000542-199308000- 00011, PMID 8192733

Saxena AK, Arava SK. Current concepts in neuraxial administration of opioids: An overview and future perspectives. Indian J Anaesth 2004;48:13-24.

Annavarapu VR, Songa VK, Sravanthi AK. Evaluation of effective low dose bupivacaine with fentanyl in spinal anesthesia for lower segment caesarean section surgeries. IOSR JPBS 2015;10:1-6.

Bromage PR. A comparison of hydrochloride and carbon dioxide salts of lidocaine and prilocaine in epidural analgesia. Acta Anaesthesiol Scand Suppl 1965;16:55-69.

Campbell DC, Camann WR, Datta S. The addition of bupivacaine to intrathecal sufentanil for labour analgesia. Anesth Analg 1995;81:305-9. doi: 10.1097/00000539-199508000-00017, PMID 7618720

Swain A, Nag DS, Sahu S, Samaddar DP. Adjuvants to local anesthetics: Current understanding and future trends. World J Clin Cases 2017;5:307-23. doi: 10.12998/wjcc.v5.i8.307, PMID 28868303

Biswas BN, Rudra A, Bose BK, Nath S, Chakrabarty S, Bhattachaejee S. Intrathecal fentanyl with hyperbaric bupivacaine improves analgesic during caesarean delivery and in early post-operative period. Indian J Anaesth 2002;46:469-72.

Sheikh F, Ahmed M, Ommid M, Gurcoo S, Shakoor N, Nazir S, et al. Comparative evaluation of low dose hyperbaric bupivacaine with or without fentanyl in spinal anaesthesia for caesarean section in patients with pregnancy induced hypertension. Internet J Anesthesiol 2013;31:1-7.

Shende D, Cooper GM, Bowden MI. The influence of intrathecal fentanyl on the characteristics of subarachnoid block for caesarean section. Anaesthesia 1998;53:706-10. doi: 10.1046/j.1365- 2044.1998.329-az0482.x, PMID 9771182

Hunt CO, Naulty JS, Bader AM, Hauch MA, Vartikar JV, Datta S, et al. Perioperative analgesia with subarachnoid fentanyl-bupivacaine for cesarean delivery. Anesthesiology 1989;71:535-40. doi: 10.1097/00000542-198910000-00009, PMID 2679237

Choi DH, Ahn HJ, Kim MH. Bupivacaine sparing effect of fentanyl in spinal anaesthesia for caesarean delivery. Reg Anesth Pain Med 2000;25:240-5. doi: 10.1016/s1098-7339(00)90005-1, PMID 10834777

Obara M, Sawamura S, Satoh Y, Chinzei M, Sekiyama H, Tamai H, et al. The effect of intrathecal fentanyl added to hyperbaric bupivacaine for caesarean section. Masui 2003;52:378-82. PMID 12728487

Bano F, Sabbar S, Zafar S, Rafeeq N, Iqbal MN, Haider S, et al. Intrathecal fentanyl as adjunct to hyperbaric bupivacaine in spinal anesthesia for caesarean section. J Coll Physicians Surg Pak 2006;16:87-90. doi: 2.2006/JCPSP.8790, PMID 16499796

Rudra P, Rudra A. Comparison of intrathecal fentanyl and midazolam for prevention of nausea-vomiting during Caesarian delivery under spinal anaesthesia. Indian J Anaesth 2004;48:461-4.

Bogra J, Arora N, Srivastava P. Synergistic effect of intrathecal fentanyl and bupivacaine in spinal anesthesia for cesarean section. BMC Anesthesiol 2005;5:5. doi: 10.1186/1471-2253-5-5, PMID 15904498

Gauchan S, Thapa C, Prasai A, Pyakurel K, Joshi I, Tulachan J. Effects of intrathecal fentanyl as an adjunct to hyperbaric bupivacaine in spinal anesthesia for elective caesarean section. Nepal Med Coll J 2014;16:5-8. PMID 25799801

Ben-David B, Miller G, Gavriel R, Gurevitch A. Low dose bupivacaine with fentanyl in spinal anaesthesia for caesarean delivery. Reg Anesth Pain Med 2000;25:235-9, PMID 10834776

Shaikh SI, Govindaraju C, Hegade G. Comparison of intrathecal fentanyl and midazolam for prevention of nausea-vomiting during cesarean section under spinal anesthesia. Anaesth Pain Intensive Care 2015;18:124-9.

Sadegh A, Tazeh-Kand NF, Eslami B. Intrathecal fentanyl for prevention of shivering in spinal anesthesia in cesarean section. Med J Islam Repub Iran 2012;26:85-9. PMID 23483276

Chu CC, Shu SS, Lin SM, Chu NW, Leu YK, Tsai SK, et al. The effect of intrathecal bupivacaine with combine fentanyl in caesarean section. Acta Anaesthesiol Sin 1995;33:149-54.

Herman NL, Choi KC, Affleck PJ, Calicott R, Brackin R, Singhal A, et al. Analgesia, pruritus, and ventilation exhibit a dose-response relationship in parturients receiving intrathecal fentanyl during labor. Anesth Analg 1999;89:378-83. doi: 10.1097/00000539-199908000- 00024, PMID 10439751

Published

07-12-2022

How to Cite

PRAJAPATI, J., R. BAYER, and H. PRAJAPATI. “COMPARISON OF BUPIVACAINE VERSUS BUPIVACAINE WITH FENTANYL INTRATHECALLY IN CESAREAN SECTION”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 12, Dec. 2022, pp. 103-6, doi:10.22159/ajpcr.2022.v15i12.45924.

Issue

Section

Original Article(s)